206 related articles for article (PubMed ID: 7649082)
1. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
Confort C; Rochefort H; Vignon F
Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
[TBL] [Abstract][Full Text] [Related]
2. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
3. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
4. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
De Leon DD; Terry C; Asmerom Y; Nissley P
Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
Lee JS; Weiss J; Martin JL; Scott CD
Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
[TBL] [Abstract][Full Text] [Related]
10. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
[TBL] [Abstract][Full Text] [Related]
11. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).
Fottner C; Engelhardt D; Weber MM
Horm Metab Res; 1999; 31(2-3):203-8. PubMed ID: 10226803
[TBL] [Abstract][Full Text] [Related]
12. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins.
Fottner C; Engelhardt D; Weber MM
J Endocrinol; 1998 Sep; 158(3):409-17. PubMed ID: 9846170
[TBL] [Abstract][Full Text] [Related]
13. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins.
Weber MM; Simmler P; Fottner C; Engelhardt D
Endocrinology; 1995 Sep; 136(9):3714-20. PubMed ID: 7544271
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II).
De León DD; Issa N; Nainani S; Asmerom Y
Horm Metab Res; 1999; 31(2-3):142-7. PubMed ID: 10226795
[TBL] [Abstract][Full Text] [Related]
16. Human IM-9 lymphoblasts as a model of the growth hormone-insulin-like growth factor axis: gene expression, and interactions of ligands with receptors and binding proteins.
Yang Y; Hoeflich A; Kessler U; Barenton B; Blum W; Schwarz HP; Kiess W
Regul Pept; 1993 Oct; 48(1-2):41-53. PubMed ID: 8265816
[TBL] [Abstract][Full Text] [Related]
17. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
Mathieu M; Vignon F; Capony F; Rochefort H
Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
[TBL] [Abstract][Full Text] [Related]
18. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
Daws MR; Westley BR; May FE
Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
